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Abstract
Aims Critical appraisal of secondary data made available
by the OECD for the time frame 2000–2011.
Methods Comparison of trends and variation of amputations
in people with diabetes across OECD countries. Generalized
estimating equations to test the statistical significance of the
annual change adjusting for major potential confounders.
Results A total of 26 OECD countries contributed to the
OECD data collection for at least 1 year in the reference
time frame, showing a decline in rates of over 40 %, from a
mean of 13.2 (median 9.4, range 5.1–28.1) to 7.8 amputa-
tions per 100,000 in the general population (9.9, 1.0–18.4).
The multivariate model showed an average decrease equal to
-0.27 per 100,000 per year (p = 0.015), adjusted by
structural characteristics of health systems, showing lower
amputation rates for health systems financed by public
taxation (-4.55 per 100,000 compared to insurance based,
p = 0.002) and non-ICD coding mechanisms (-7.04 per
100,000 compared to ICD-derived, p = 0.001). Twelve-year
decrease was stronger among insurance-based financing
systems (tax based: -0.16 per 100,000, p = 0.064; insur-
ance based: -0.36 per 100,000; p = 0.046).
Conclusions In OECD countries, amputation rates in dia-
betes continuously decreased over 12 years. Still, in 2011,
one amputation every 7 min could be directly attributed to
diabetes. Although interesting, these results should be
taken with extreme caution, until common definitions are
improved and data quality issues, e.g., a different ability in
capturing diabetes diagnoses, are fully resolved.
Keywords Lower extremity amputation  Diabetes 
OECD  Health care quality indicators  Health systems
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Introduction
Although recognized as an essential target in the clinical
management of a person with diabetes, use of lower
extremity amputations at system level appears still limited
and highly controversial [1].
In 1989, the St.Vincent Declaration launched by WHO
Europe and IDF Europe triggered the attention of govern-
ments on ‘‘reducing by one half the rate of limb amputa-
tions for diabetic gangrene’’ [2]. After over 25 years, there
is still insufficient information available at the international
level to monitor progress in this direction [3].
The relatively few national audits routinely reporting
lower extremity amputations rates in diabetes (LEARD)
show a consistent reduction over the years, with a steady
state reached in several cases [4–11].
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Since 2001, the Organization for Economic Cooperation
and Development (OECD) has been collecting a series of
indicators as a core activity of the ‘‘Health Care Quality
Indicators’’ (HCQI) Project [12], with the aim of developing
and reporting international comparisons on the various
dimensions of quality of care within a broader conceptual
framework of health systems performance [13].
Data collection on LEARD started in 2006 as one of the
indicators included in the ‘‘primary care’’ theme of the
HCQI. However, annual trends were never published in
‘‘Health at a Glance,’’ the biannual flagship HCQI publi-
cation targeted at the broad audience [14].
The main reason for not publishing the international trends
of LEARD was a general disagreement among countries on
how to cope with the observed variability in the results, how to
consider the different coding mechanisms and data sources
used to apply common definitions, and which methods would
be required for statistical analysis. Consequently, the avail-
ability of these data has been substantially underexploited.
Meanwhile, LEARD data collected by the OECD have been
regularly uploaded to the official OECD online repository
StatExtracts (http://stats.oecd.org/).
In the present paper, we present the results of a critical
appraisal of the LEARD data collected by the OECD for
the years 2000–2011, with the aim of responding to the
following main questions:
• How was the trend over 12 years?
• How did rates vary across OECD countries in each
year?
• Can amputation rates be used to evaluate quality of care
and health systems performance?
• How to enhance international comparability?
Materials and methods
Standardized LEARD for the time frame 2000–2011 were
downloaded from StatExtracts in May 2015, with data
referred to the HCQI data collection 2013.
The entire time series was computed by the OECD,
using numerators/denominators stratified by sex and age
classes, delivered by countries on the basis of the following
agreed criteria:
• Numerators include all non-maternal/non-neonatal hos-
pital admissions of subjects aged 15 or over with
procedure code of lower extremity amputation (excluding
toe) and diagnosis code of diabetes in any field in a
specified year. Specific procedure codes (84.10, 84.12–19)
were provided only for ICD-9-CM and ICD-10-WHO. In
other cases, countries were asked to identify the most
appropriate codes for their national classification systems.
• Cases are excluded from the numerators if they are
transferred from another institution or present a trauma
diagnosis, or same day/day only admissions.
• Denominators refer to the total population aged
15 years or over.
• All rates are expressed as the total number of ampu-
tations 9100,000 total general population, standardized
(SR) using the total OECD population across 34
member states (MS) in year 2005.
Additional data extracted from the OECD online
repository included structural characteristics of data (use of
registries and coding systems) and health systems of par-
ticipating countries (tax-based systems vs insurance based)
[15].
Since the USA included amputation of toes in the
numerator before 2010, all data reported prior to that date
were excluded from the analysis.
Descriptive measures included: measures of centrality
(mean, median and range); dispersion (coefficient of vari-
ation x 100: CV), total general population aged 15 and over
in all 34 MS; and projected total number of amputations per
year (computed as a product between the total population
and the relative standardized rate). A graphical plot super-
imposing boxplots to turnip charts and a continuous line
representing the average trend for the entire pool of OECD
countries, was used to display results over time [16].
Multivariate linear regression using generalized estimating
equations (GEE) was used to estimate the average change of
standardized LEARD over time, taking into account all
structural characteristics identified above as potential con-
founders and including countries as clusters, with an
exchangeable correlation matrix of rates over time. The
adoption of GEE models was justified by the need of ensuring
robust confidence intervals when the normality assumption is
violated by correlated values within clusters (in this case,
countries) and missing data are sparsely present [17].
Sensitivity analysis was carried out to take into account
the different composition of countries over time, testing the
heterogeneity of results obtained for the whole period
against those excluding observations prior to 2006, when a
limited set of countries was included in the database. The
GEE model allowed using all information available at each
point in time, rather than just the annual average.
All analyses were performed using the R statistical
language [18].
Results
An expanded version of the OECD data on LEARD for the
time frame 2000–2011 is presented in Table 1 reporting
standardized rates for each contributing country.
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Descriptive measures and the projected total number of
amputations in the whole OECD area are presented in
Table 2.
A total of 26 OECD countries contributed to the HCQI
data collection on LEARD with at least one year in the
reference time frame. One half of MS presents only data
from 2006 onwards. A total of 8 MS did not participate and
were only considered for the total population used for
standardization: Austria, Chile, Czech Republic, Estonia,
Greece, Japan, Slovak Republic and Turkey.
Overall, standardized LEARD experienced a 12-year
decline of over 40 %, from a mean of 13.2 amputations per
100,000 in 2000 (median, range: 9.4, 5.1–28.1) to a mean
of 7.8 amputations per 100,000 in 2011 (9.9, 1.0–18.4).
The average reduction appeared to be consistently linear
over time (Fig. 1), with the exception of 2007, a year in which
Germany entered the time series with a very high value.
The coefficient of variation is very high across the whole
period, although declining fairly linearly from 73.7 % in
2000 to 57.2 % in 2011. In this year, we still find values as
high as 18.4 per 100,000 for Germany, as opposed to its
near neighbor country, Hungary, which reports a very low
value of 1.1 per 100,000.
The results produced using only rates from 2006 onwards
did not substantially differ from those relative to the whole
time frame. Therefore, the GEE outputs presented in Table 3
refer to all information available between 2000 and 2011.
The first model shows that LEARD have significantly
decreased on average by -0.27 per 100,000 per year (95 %
CI: -0.50, -0.05; p = 0.015), equal to -3.30 per 100,000
over 12 years, adjusted by financing mechanism, use of
registry and coding system.
Countries with a tax-based financing system present a
significant difference in standardized LEARD equal to
-4.55 per 100,000 (95 %CI: -8.38, -0.72; p = 0.002).
Using a registry as a data source, albeit not significant
(?2.9 per 100,000, 95 %CI: -2.03, 7.8925; p = 0.247),
was retained into the model to ensure adjustment for a
potential confounder.
No significant difference was found between countries
using ICD-9 vs ICD-10. Thus, the two categories were
merged in a reference category against non-ICD classifi-
cation systems, the latter presenting significantly lower
amputation rates equal to -7.04 per 100,000 (95 %CI:
-11.24, -2.84; p = 0.001).
The GEE models separately run on tax-based vs insurance-
based health systems revealed that the reduction in LEARD
was not homogeneous among groups. Among tax-based
systems (Model 2), the annual decrease was low and not
significant (-0.16, p = 0.064), while insurance-based health
systems (Model 3) showed a statistically significant, stronger
than average decrease equal to -0.36 per 100,000 (95 %CI:
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Notably, tax-based countries started from a much lower
average level of LEARD compared to insurance-based
(7.55 vs 17.50 per 100,000 in 2000, as opposed to 6.25 vs
8.15 per 100,000 in 2011). These results indicate that the
relative performance of countries may depend upon vary-
ing characteristics as well as the trend dynamics.
Discussion
The revised analysis of the OECD data relative to 12
consecutive years suggests relevant answers to our initial
set of questions. The confirmed links between lower limb
amputations, disability and excess mortality [19–21] call
for immediate action on a global scale. In 2011, across the
whole OECD area, over 216 amputations per day could be
directly attributed to diabetes.
The variability between countries is still relevant and in
certain cases difficult to explain: Germany has a rate of
over 18 times higher than Hungary (18.4 vs 1.1 per
100,000). Imbalances in the prevalence of diabetes may
represent a potential primary reason, but there might be
also other possible explanations, involving different types
of factors.
For instance, the result for Germany may be biased by a
higher number of minor amputations in the numerator or
lack of accurate data, given that there is no national register















































































































































































Fig. 1 Lower extremity amputation rates in diabetes, OECD 2000-2011





survey, 2012; health care
quality indicators project
(revised version, data collection
2013)
Model/Variable Estimate S.E. 95 %C.I. P[Z
Model 1 [Complete dataset; N countries = 26]
Tax-based system -4.55 1.95 -8.38, -0.72 0.020
Use of registry 2.93 2.53 -2.03, 7.89 0.247
Non-ICD coding -7.04 2.14 -11.24, -2.84 0.001
Average year change -0.27 0.11 -0.50, -0.05 0.015
Model 2 [Financing: Tax-based; N countries = 12; Median LEARD: 7.55 (2000), 6.25 (2011)]
Average Year Change -0.16 0.09 -0.33, 0.01 0.064
Model 2 [Financing: Social insurance; N countries = 14; Median LEARD: 17.50 (2000), 8.15 (2011)]
Average year change -0.36 0.18 -0.71, -0.01 0.046
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a recent publication highlighted a lack of guideline
adherence in managing peripheral arterial disease and
critical limb ischemia [22].
On the other hand, data reported for Hungary seem
particularly unclear, with rates remaining fairly stable at
minimal levels since 2004. The fact that other countries
with long-standing tradition in diabetes foot care present
significantly higher values may question the comparability
of these national results.
Across the whole time frame, there has been a statistical
significant reduction in amputation rates in diabetes, indi-
cating a potential beneficial effect of guidelines and poli-
cies implemented by all countries to enhance the quality of
care for diabetes patients. Adjusting by the main potential
confounders, the overall reduction in standardized rates
over 12 years was equal to -3.30 per 100,000, slightly
lower than the difference by over 40 % between the
average rates of 2000–2011, which can be interpreted as a
remarkable success.
Projected over the entire OECD total general popula-
tion, the overall reduction in average standardized rates
translates into an estimated decrease in the absolute num-
ber of amputations in diabetes corresponding to 41,405 per
year, from 120,348 in 2000 to 78,943 in 2011. Such a
decrease is also accompanied by a similar trend toward
lower variation between countries, as shown by decreasing
coefficients of variation. These results appear particularly
positive, considering the general increase in the prevalence
of diabetes experienced worldwide during the same time
interval [23].
The results appear more controversial when comparing
health systems with different funding mechanisms. The
average difference in favor of tax-based vs insurance-based
systems is equal to 4.5 per 100,000 diabetic amputations.
On the other hand, the improvement has been stronger for
insurance-based systems, corresponding to a significant
decrease of -0.36 per 100,000 per year. This can be lar-
gely explained by the fact that the starting point was much
higher for that group of countries. In fact, the two financing
groups correspond to high and low performers in an
alternate way, depending on whether one considers a point
in the time series or the average improvement over time.
The above results seem to highlight recent successes as
well as enduring challenges in the planned reduction in
amputation rates in people with diabetes. Although
interesting, they should be also taken with extreme caution.
In the OECD data collection, countries are fully in
charge of ensuring accurate reporting of cases of diabetes.
Therefore, we could not assess to what extent a systematic
underreporting of diabetes diagnoses may have determined
lower rates in specific cases. Until data quality issues such
as this one are not fully resolved, the level of association
found between insurance-based systems and higher rates
should be only used to raise hypotheses for further inves-
tigation, but by no means can be intended as a cause–effect
relationship.
On the other hand, the significantly lower rates found for
countries using non-ICD classification systems should not
be interpreted in relation to data quality. In fact, systems,
e.g., NOMESCO, are prevalently used in countries (e.g.,
the Nordic) that apply data linkage more extensively, use
more quality registries and thus are more likely to report
accurate numerators (as indirectly confirmed by the coef-
ficient of registry use in the multivariate model). Potential
bias may have been induced by the inclusion of specifi-
cations only related to ICD systems in the OECD guide-
lines. The inclusion of coding as an adjustment term in the
multivariate model provided us with a more balanced
estimate of the average annual reduction in amputations.
The inclusion of additional potential confounders, e.g.,
diabetes prevalence, was discarded for specific reasons.
Firstly, because stratified estimates of disease-oriented
measures, e.g., diabetes prevalence, are still difficult to
obtain from national governments, while our approach is
based only on official data. Secondly, because it would be
preferable not to adjust for factors that could be directly
associated to health systems performance, a point of major
interest in the present study. As a matter of fact, diabetes-
related factors were embedded in the overall measurement
of quality of care provided by LEARD in the general
population (consistently with the denominator).
Specific methodological recommendations can be sug-
gested for future data collection:
• Further efforts must be made to embed in the data
collection means to ascertain (and possibly reduce) any
cause of systematic underreporting of diabetes diag-
noses (as in the case of Hungary).
• Data are still of insufficient granularity to draw
conclusions on quality of care.
– How to interpret the reported reduction when
considering major vs minor amputations? Minor
amputations may indicate better quality of care as
an intervention to prevent major ones and hence
salvage lower extremities. A stable number of the
total number of amputations, or even an increase,
may actually hide a higher number of minor vs
major, which in turn should be interpreted as a
better performance. However, the data collection
presented here cannot capture the clinical relevance
of minor and major amputations. To this end, the
OECD indicator should explicitly distinguish them.
– Amputation rates calculated over the total general
population may hide significant improvements in
the quality of care provided to a higher number of
subjects with diabetes, as certified by the steep
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global increase in prevalence. To provide unbiased
comparisons between countries, it is essential that
the OECD denominator is only referring to the
number of subjects with diabetes.
– Further refinement would require avoiding double
counts of amputations and referring to the percentage
of subjects with diabetes experiencing major vs
minor amputations. In this case, it would be prefer-
able to monitor patients over time through a unique
patient identifier, considering only the most severe
amputation within a year to classify an amputee in
either the ‘‘minor’’ or the ‘‘major’’ category at each
term.
The above improvements to indicator reporting would
allow testing the validity of our results in more detail,
confirming the existence of significant differences between
countries that can lead to active interventions.
International organizations, e.g., the OECD, should
specifically use this knowledge to influence the identifica-
tion of effective policies for quality of care improvement.
In particular, the observed advantage of tax-based sys-
tems in diabetes care may indicate more complicated
underlying processes that deserve to be carefully explored.
For instance, tax-based financing systems may represent
only a proxy for the different ways of organizing contin-
uous care for diabetes patients and services aimed at
reducing complications. This consideration calls for more
in depth comparisons between differing types of practices,
rather than countries.
Healthcare systems can be differently organized in terms
of chronic disease management and integrated care, or may
have different availability of specialist centers, unequal
access to treatments, e.g., insulin, reagent strips and/or lack
of solutions, e.g., specialized centers for the diabetic foot,
extensive use of health information systems, broad pres-
ence of educational programs and activities for consumers
empowerment.
On the other hand, the different ability to track diabetes
diagnoses and potential issues in the data quality affecting
LEARD estimation may not allow, at this point, to derive
definitive conclusions in this direction. More work is
required to undertake international comparisons of LEARD.
Our report suggests that the computation of amputation
rates has the potential to highlight strengths and weak-
nesses of health systems in terms of data infrastructure as
well as healthcare quality. For this reason, the OECD
should continue to retain LEARD as a useful tool in the
total set of Health Care Quality Indicators.
The present report suggests that amputation rates may
well fit the analysis of quality of care to help understanding
which policies work better, rather than producing a league
table to rank countries according to their performance.
More refined indicators will require strengthening the
information infrastructure, through the implementation of
common standards that would assure minimal data quality
requirements. This is an effort that may not be as
straightforward as it may eventually seem. To use it on a
regular basis, governments should agree upon the essential
levels of health information required to guarantee inter-
national comparability and adequate support for quality
improvement strategies [24].
We encourage the OECD to continue along this process
and further refine the definitions and data collection of
LEARD, in ways that could shed light on the result of
policies implemented at national level.
The preliminary results from the most recent OECD data
collection relative to year 2013, published in Health at a
Glance 2015, have already made a step ahead in this
direction [25].
Conclusions
Despite an overall significant reduction observed across 12
consecutive years, amputation rates among people with
diabetes remain still high in most OECD countries. In
2011, one amputation every 7 min among subjects aged 15
years or over could be directly attributed to diabetes.
Our analysis of OECD data from 26 countries shows
lower amputation rates in health systems financed by
public taxation, taking into account different coding
mechanisms. These results encourage to continue the
exploration on whether amputation rates could play a pri-
mary role in the quality matrix adopted by the OECD for
the general evaluation of health systems, in strict collabo-
ration with national governments [13].
Although interesting, these results should be taken with
extreme caution, until common definitions are improved
and data quality issues, e.g., a different ability in capturing
diabetes diagnoses, are fully resolved.
The debate on how to make the best use of the
knowledge acquired on LEARD shall continue at different
levels, along with efforts aimed at improving international
comparability. Our results provide an avenue for the
OECD to continue on this pathway, in direct collaboration
with researchers, health professionals and policy makers.
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